Pulmonary immuno-thrombosis in COVID....pdf (1.63 MB)
Download file

Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis

Download (1.63 MB)
journal contribution
posted on 04.11.2021, 16:53 by James O'DonnellJames O'Donnell, Flora Peyvandi, Ignacio Martin-Loeches
Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) is responsible for coronavirus disease 2019 (COVID-19). Recent data highlight a pivotal role for pulmonary immuno-thrombosis in COVID-19 in the pathogenesis of severe COVID-19.

Funding

Health Research Board COVID-19 Rapid Response award (COV19-2020-086)

3M Foundation to RCSI University of Medicine and Health Sciences in support of COVID-19 research

National Children’s Research Centre Project Award (C/18/1)

Italian Ministry of Health—Bando Ricerca Corrente

Italian fiscal contribution "5x1000" 2017 devolved to Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Science Foundation Ireland, Enterprise Ireland, IDA Ireland COVID-19 Rapid Response award (20/COV/0038)

History

Comments

The original article is available at https://link.springer.com

Published Citation

O'Donnell JS, Peyvandi F, Martin-Loeches I. Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis. Intensive Care Med. 2021;47(8):899-902.

Publication Date

30 May 2021

PubMed ID

34052905

Department/Unit

  • Irish Centre for Vascular Biology
  • School of Pharmacy and Biomolecular Sciences

Research Area

  • Vascular Biology

Publisher

Springer Nature

Version

  • Published Version (Version of Record)